Intrinsic Value of S&P & Nasdaq Contact Us

Amgen Inc. AMGN NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score
64/100
4/7 Pass
SharesGrow Intrinsic Value
$457.46
+30.3%
Analyst Price Target
$347.73
-0.9%

Stock Statistics — AMGN

Amgen Inc. (AMGN) has a market capitalization of $189.19B and trades at $350.95. The 52-week range is 261.43-391.29.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 24.5, Earnings Per Share (EPS) of $14.33, annual revenue of $36.74B.

The stock has a beta of 0.47, a last dividend of $9.6600, operates in the Healthcare sector.

Trading Data
Current Price$350.95
52-Week Range261.43-391.29
Volume2.11M
Avg Volume (30D)2.84M
Market Cap$189.19B
Beta (1Y)0.47
Last Dividend$9.6600
Company
IPO Date1983-06-17
Employees28,000
CEORobert A. Bradway
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS0311621009
CUSIP031162100
Income (Latest Year)
Revenue$36.74B
Gross Profit$26.01B
EBITDA$15.84B
Operating Income$10.68B
Net Income$7.71B
EPS$14.33
EPS Diluted$14.23
Shares Outstanding$538M
Balance Sheet (Latest Year)
Total Assets$90.59B
Current Assets$29.06B
Cash & ST Investments$9.13B
Total Liabilities$81.93B
Total Debt$54.6B
Net Debt$45.48B
Total Equity$8.66B
Debt / Equity6.31
Valuation Ratios
P/E Ratio24.5
P/S Ratio5.15
P/B Ratio21.85
EV/EBITDA (approx)11.9
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message